Skip to content

Reproducibility of Computed Tomography

Evaluation of the Reproducibility of Computed Tomography for the Measurement of Tuberculosis Pleural Effusion

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01616264
Enrollment
20
Registered
2012-06-11
Start date
2006-01-31
Completion date
2009-12-31
Last updated
2012-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pleural Effusion, Tuberculosis

Keywords

Tuberculosis, Pleural Effusion, Computed Tomography

Brief summary

Thus, the aim of this study was to evaluate the reproducibility of the Computed Tomograph scan three-dimensional reconstruction method for the measurement of the TB pleural effusion volume in clinically stable patients.

Detailed description

Speed, accuracy, and precision in the quantification of pleural effusion are of critical importance as it determines whether or not thoracocentesis should be carried out and which technique should be employed for such a procedure. This study evaluates the precision of thoracic computed tomography with three-dimensional (3D) rebuilding in determining the volume of tuberculosis pleural effusion.Twenty patients with pleural effusion were screened and invited to take part in the study. Each patient underwent two computed tomography scans, before and after one month of treatment for tuberculosis, a total of 40 exams. These were evaluated by two expert radiologists. In conclusion, the quantification of the pleural effusion volume by using thoracic CT with volumetric three-dimensional reconstruction is a highly reproducible method.

Interventions

None listed

Sponsors

Universidade Federal do Rio de Janeiro
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients age 18 years with a confirmed diagnosis of pleural TB effusion . * Signed out an informed consent term

Exclusion criteria

* Patients with human immunodeficiency virus (HIV).

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026